APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pre-Pregnancy Genetic Screening Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pre-Pregnancy Genetic Screening Service Market Analysis and Forecast 2026-2032

Report ID 17421905022 May 2026203 pages

Choose your research edition.

Industry ResearchPre-Pregnancy Genetic Screening Service Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pre-Pregnancy Genetic Screening Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pre-Pregnancy Genetic Screening Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pre-Pregnancy Genetic Screening Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pre-Pregnancy Genetic Screening Service Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pre-Pregnancy Genetic Screening Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pre-Pregnancy Genetic Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pre-Pregnancy Genetic Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pre-Pregnancy Genetic Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pre-Pregnancy Genetic Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pre-Pregnancy Genetic Screening Service include Invitae, Natera, Fulgent Genetics, Myriad Genetics, Quest Diagnostics, LabCorp, GeneDx, Vitrolife and Illumina, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pre-Pregnancy Genetic Screening Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pre-Pregnancy Genetic Screening Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pre-Pregnancy Genetic Screening Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pre-Pregnancy Genetic Screening Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pre-Pregnancy Genetic Screening Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pre-Pregnancy Genetic Screening Service revenue, projected growth trends, production technology, application and end-user industry.

Pre-Pregnancy Genetic Screening Service Segment by Company

Invitae

Natera

Fulgent Genetics

Myriad Genetics

Quest Diagnostics

LabCorp

GeneDx

Vitrolife

Illumina

BillionToOne

Juno Genetics

MedGenome

23andMe

Sonic Genetics

CEN4GEN

BGI Genomics

Berry Genomics

Anoroad

KingMed Diagnostics

CapitalBio Technology

Pre-Pregnancy Genetic Screening Service Segment by Type

Single Disease Screening

Whole Genome Screening

Pre-Pregnancy Genetic Screening Service Segment by Application

Medical and Health Institutions

Research and Educational Institutions

Others

Pre-Pregnancy Genetic Screening Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Pregnancy Genetic Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pre-Pregnancy Genetic Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Pregnancy Genetic Screening Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pre-Pregnancy Genetic Screening Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pre-Pregnancy Genetic Screening Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Pregnancy Genetic Screening Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Disease Screening Major Player Table 3. Whole Genome Screening Major Player Table 4. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical and Health Institutions Major Player Table 6. Research and Educational Institutions Major Player Table 7. Others Major Player Table 8. Pre-Pregnancy Genetic Screening Service Industry Trends Table 9. Pre-Pregnancy Genetic Screening Service Industry Drivers Table 10. Pre-Pregnancy Genetic Screening Service Industry Opportunities and Challenges Table 11. Pre-Pregnancy Genetic Screening Service Industry Restraints Table 12. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pre-Pregnancy Genetic Screening Service Market Share by Region (2021-2026) Table 15. Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pre-Pregnancy Genetic Screening Service Market Share by Region (2027-2032) Table 17. Global Pre-Pregnancy Genetic Screening Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Players (2021-2026) Table 19. Global Pre-Pregnancy Genetic Screening Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pre-Pregnancy Genetic Screening Service Key Players Headquarters & Area Served Table 21. Global Pre-Pregnancy Genetic Screening Service Players, Product Type & Application Table 22. Global Pre-Pregnancy Genetic Screening Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pre-Pregnancy Genetic Screening Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pre-Pregnancy Genetic Screening Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Type (2021-2026) Table 29. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Type (2027-2032) Table 30. Global Pre-Pregnancy Genetic Screening Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2021-2026) Table 34. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2027-2032) Table 35. Invitae Company Information Table 36. Invitae Business Overview Table 37. Invitae Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio Table 39. Invitae Recent Development Table 40. Natera Company Information Table 41. Natera Business Overview Table 42. Natera Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Natera Pre-Pregnancy Genetic Screening Service Product Portfolio Table 44. Natera Recent Development Table 45. Fulgent Genetics Company Information Table 46. Fulgent Genetics Business Overview Table 47. Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 49. Fulgent Genetics Recent Development Table 50. Myriad Genetics Company Information Table 51. Myriad Genetics Business Overview Table 52. Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 54. Myriad Genetics Recent Development Table 55. Quest Diagnostics Company Information Table 56. Quest Diagnostics Business Overview Table 57. Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 59. Quest Diagnostics Recent Development Table 60. LabCorp Company Information Table 61. LabCorp Business Overview Table 62. LabCorp Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio Table 64. LabCorp Recent Development Table 65. GeneDx Company Information Table 66. GeneDx Business Overview Table 67. GeneDx Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio Table 69. GeneDx Recent Development Table 70. Vitrolife Company Information Table 71. Vitrolife Business Overview Table 72. Vitrolife Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio Table 74. Vitrolife Recent Development Table 75. Illumina Company Information Table 76. Illumina Business Overview Table 77. Illumina Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio Table 79. Illumina Recent Development Table 80. BillionToOne Company Information Table 81. BillionToOne Business Overview Table 82. BillionToOne Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio Table 84. BillionToOne Recent Development Table 85. Juno Genetics Company Information Table 86. Juno Genetics Business Overview Table 87. Juno Genetics Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 89. Juno Genetics Recent Development Table 90. MedGenome Company Information Table 91. MedGenome Business Overview Table 92. MedGenome Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio Table 94. MedGenome Recent Development Table 95. 23andMe Company Information Table 96. 23andMe Business Overview Table 97. 23andMe Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio Table 99. 23andMe Recent Development Table 100. Sonic Genetics Company Information Table 101. Sonic Genetics Business Overview Table 102. Sonic Genetics Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 104. Sonic Genetics Recent Development Table 105. CEN4GEN Company Information Table 106. CEN4GEN Business Overview Table 107. CEN4GEN Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio Table 109. CEN4GEN Recent Development Table 110. BGI Genomics Company Information Table 111. BGI Genomics Business Overview Table 112. BGI Genomics Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 114. BGI Genomics Recent Development Table 115. Berry Genomics Company Information Table 116. Berry Genomics Business Overview Table 117. Berry Genomics Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 119. Berry Genomics Recent Development Table 120. Anoroad Company Information Table 121. Anoroad Business Overview Table 122. Anoroad Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio Table 124. Anoroad Recent Development Table 125. KingMed Diagnostics Company Information Table 126. KingMed Diagnostics Business Overview Table 127. KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 129. KingMed Diagnostics Recent Development Table 130. CapitalBio Technology Company Information Table 131. CapitalBio Technology Business Overview Table 132. CapitalBio Technology Pre-Pregnancy Genetic Screening Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio Table 134. CapitalBio Technology Recent Development Table 135. North America Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Pre-Pregnancy Genetic Screening Service Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (US$ Million) & (2027-2032) Table 149. China Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 150. China Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 151. China Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 152. China Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Pre-Pregnancy Genetic Screening Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Pre-Pregnancy Genetic Screening Service Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Pre-Pregnancy Genetic Screening Service Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Pre-Pregnancy Genetic Screening Service Image Figure 2. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pre-Pregnancy Genetic Screening Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Disease Screening Image Figure 5. Whole Genome Screening Image Figure 6. Global Pre-Pregnancy Genetic Screening Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pre-Pregnancy Genetic Screening Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical and Health Institutions Image Figure 9. Research and Educational Institutions Image Figure 10. Others Image Figure 11. Global Pre-Pregnancy Genetic Screening Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Pre-Pregnancy Genetic Screening Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pre-Pregnancy Genetic Screening Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pre-Pregnancy Genetic Screening Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Type (2021-2032) Figure 19. Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2021-2032) Figure 22. North America Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032) Figure 24. North America Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032) Figure 25. North America Pre-Pregnancy Genetic Screening Service Revenue Share by Country (2021-2032) Figure 26. United States Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032) Figure 31. Europe Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032) Figure 32. Europe Pre-Pregnancy Genetic Screening Service Revenue Share by Country (2021-2032) Figure 33. Germany Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032) Figure 43. China Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032) Figure 44. Asia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032) Figure 46. Asia Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032) Figure 47. Asia Pre-Pregnancy Genetic Screening Service Revenue Share by Region (2021-2032) Figure 48. Japan Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Pre-Pregnancy Genetic Screening Service Revenue Share by Country (2021-2032) Figure 58. Brazil Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pre-Pregnancy Genetic Screening Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single Disease Screening
  • Whole Genome Screening
Applications
  • Medical and Health Institutions
  • Research and Educational Institutions
  • Others
Companies covered
  • Invitae
  • Natera
  • Fulgent Genetics
  • Myriad Genetics
  • Quest Diagnostics
  • LabCorp
  • GeneDx
  • Vitrolife
  • Illumina
  • BillionToOne
  • Juno Genetics
  • MedGenome
  • 23andMe
  • Sonic Genetics
  • CEN4GEN
  • BGI Genomics
  • Berry Genomics
  • Anoroad
  • KingMed Diagnostics
  • CapitalBio Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pre-Pregnancy Genetic Screening Service Market by Type
  3. 1.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Disease Screening
  5. 1.2.3 Whole Genome Screening
  6. 1.3 Pre-Pregnancy Genetic Screening Service Market by Application
  7. 1.3.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical and Health Institutions
  9. 1.3.3 Research and Educational Institutions
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pre-Pregnancy Genetic Screening Service Market Dynamics
  1. 2.1 Pre-Pregnancy Genetic Screening Service Industry Trends
  2. 2.2 Pre-Pregnancy Genetic Screening Service Industry Drivers
  3. 2.3 Pre-Pregnancy Genetic Screening Service Industry Opportunities and Challenges
  4. 2.4 Pre-Pregnancy Genetic Screening Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pre-Pregnancy Genetic Screening Service Market Perspective (2021-2032)
  2. 3.2 Global Pre-Pregnancy Genetic Screening Service Growth Trends by Region
  3. 3.2.1 Global Pre-Pregnancy Genetic Screening Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pre-Pregnancy Genetic Screening Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pre-Pregnancy Genetic Screening Service Revenue by Players
  2. 4.1.1 Global Pre-Pregnancy Genetic Screening Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pre-Pregnancy Genetic Screening Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pre-Pregnancy Genetic Screening Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pre-Pregnancy Genetic Screening Service Key Players Headquarters & Area Served
  7. 4.4 Global Pre-Pregnancy Genetic Screening Service Players, Product Type & Application
  8. 4.5 Global Pre-Pregnancy Genetic Screening Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pre-Pregnancy Genetic Screening Service Market CR5 and HHI
  11. 4.6.3 2025 Pre-Pregnancy Genetic Screening Service Tier 1, Tier 2, and Tier 3
5 Pre-Pregnancy Genetic Screening Service Market Size by Type
  1. 5.1 Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 5.3 Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Type (2021-2032)
6 Pre-Pregnancy Genetic Screening Service Market Size by Application
  1. 6.1 Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  3. 6.3 Global Pre-Pregnancy Genetic Screening Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Invitae
  2. 7.1.1 Invitae Company Information
  3. 7.1.2 Invitae Business Overview
  4. 7.1.3 Invitae Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio
  6. 7.1.5 Invitae Recent Developments
  7. 7.2 Natera
  8. 7.2.1 Natera Company Information
  9. 7.2.2 Natera Business Overview
  10. 7.2.3 Natera Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Natera Pre-Pregnancy Genetic Screening Service Product Portfolio
  12. 7.2.5 Natera Recent Developments
  13. 7.3 Fulgent Genetics
  14. 7.3.1 Fulgent Genetics Company Information
  15. 7.3.2 Fulgent Genetics Business Overview
  16. 7.3.3 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  18. 7.3.5 Fulgent Genetics Recent Developments
  19. 7.4 Myriad Genetics
  20. 7.4.1 Myriad Genetics Company Information
  21. 7.4.2 Myriad Genetics Business Overview
  22. 7.4.3 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  24. 7.4.5 Myriad Genetics Recent Developments
  25. 7.5 Quest Diagnostics
  26. 7.5.1 Quest Diagnostics Company Information
  27. 7.5.2 Quest Diagnostics Business Overview
  28. 7.5.3 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
  30. 7.5.5 Quest Diagnostics Recent Developments
  31. 7.6 LabCorp
  32. 7.6.1 LabCorp Company Information
  33. 7.6.2 LabCorp Business Overview
  34. 7.6.3 LabCorp Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio
  36. 7.6.5 LabCorp Recent Developments
  37. 7.7 GeneDx
  38. 7.7.1 GeneDx Company Information
  39. 7.7.2 GeneDx Business Overview
  40. 7.7.3 GeneDx Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio
  42. 7.7.5 GeneDx Recent Developments
  43. 7.8 Vitrolife
  44. 7.8.1 Vitrolife Company Information
  45. 7.8.2 Vitrolife Business Overview
  46. 7.8.3 Vitrolife Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio
  48. 7.8.5 Vitrolife Recent Developments
  49. 7.9 Illumina
  50. 7.9.1 Illumina Company Information
  51. 7.9.2 Illumina Business Overview
  52. 7.9.3 Illumina Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio
  54. 7.9.5 Illumina Recent Developments
  55. 7.10 BillionToOne
  56. 7.10.1 BillionToOne Company Information
  57. 7.10.2 BillionToOne Business Overview
  58. 7.10.3 BillionToOne Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio
  60. 7.10.5 BillionToOne Recent Developments
  61. 7.11 Juno Genetics
  62. 7.11.1 Juno Genetics Company Information
  63. 7.11.2 Juno Genetics Business Overview
  64. 7.11.3 Juno Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  66. 7.11.5 Juno Genetics Recent Developments
  67. 7.12 MedGenome
  68. 7.12.1 MedGenome Company Information
  69. 7.12.2 MedGenome Business Overview
  70. 7.12.3 MedGenome Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio
  72. 7.12.5 MedGenome Recent Developments
  73. 7.13 23andMe
  74. 7.13.1 23andMe Company Information
  75. 7.13.2 23andMe Business Overview
  76. 7.13.3 23andMe Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio
  78. 7.13.5 23andMe Recent Developments
  79. 7.14 Sonic Genetics
  80. 7.14.1 Sonic Genetics Company Information
  81. 7.14.2 Sonic Genetics Business Overview
  82. 7.14.3 Sonic Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  84. 7.14.5 Sonic Genetics Recent Developments
  85. 7.15 CEN4GEN
  86. 7.15.1 CEN4GEN Company Information
  87. 7.15.2 CEN4GEN Business Overview
  88. 7.15.3 CEN4GEN Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio
  90. 7.15.5 CEN4GEN Recent Developments
  91. 7.16 BGI Genomics
  92. 7.16.1 BGI Genomics Company Information
  93. 7.16.2 BGI Genomics Business Overview
  94. 7.16.3 BGI Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
  96. 7.16.5 BGI Genomics Recent Developments
  97. 7.17 Berry Genomics
  98. 7.17.1 Berry Genomics Company Information
  99. 7.17.2 Berry Genomics Business Overview
  100. 7.17.3 Berry Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
  102. 7.17.5 Berry Genomics Recent Developments
  103. 7.18 Anoroad
  104. 7.18.1 Anoroad Company Information
  105. 7.18.2 Anoroad Business Overview
  106. 7.18.3 Anoroad Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio
  108. 7.18.5 Anoroad Recent Developments
  109. 7.19 KingMed Diagnostics
  110. 7.19.1 KingMed Diagnostics Company Information
  111. 7.19.2 KingMed Diagnostics Business Overview
  112. 7.19.3 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
  114. 7.19.5 KingMed Diagnostics Recent Developments
  115. 7.20 CapitalBio Technology
  116. 7.20.1 CapitalBio Technology Company Information
  117. 7.20.2 CapitalBio Technology Business Overview
  118. 7.20.3 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio
  120. 7.20.5 CapitalBio Technology Recent Developments
8 North America
  1. 8.1 North America Pre-Pregnancy Genetic Screening Service Revenue (2021-2032)
  2. 8.2 North America Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032)
  5. 8.3 North America Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032)
  9. 8.5 North America Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pre-Pregnancy Genetic Screening Service Revenue by Country
  11. 8.6.1 North America Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pre-Pregnancy Genetic Screening Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pre-Pregnancy Genetic Screening Service Revenue (2021-2032)
  2. 9.2 Europe Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pre-Pregnancy Genetic Screening Service Revenue by Country
  11. 9.6.1 Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pre-Pregnancy Genetic Screening Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pre-Pregnancy Genetic Screening Service Revenue (2021-2032)
  2. 10.2 China Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032)
  5. 10.3 China Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032)
  9. 10.5 China Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pre-Pregnancy Genetic Screening Service Revenue (2021-2032)
  2. 11.2 Asia Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pre-Pregnancy Genetic Screening Service Revenue by Country
  11. 11.6.1 Asia Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pre-Pregnancy Genetic Screening Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pre-Pregnancy Genetic Screening Service Revenue (2021-2032)
  2. 12.2 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pre-Pregnancy Genetic Screening Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pre-Pregnancy Genetic Screening Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country
  11. 12.6.1 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pre-Pregnancy Genetic Screening Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst